Ototoxicity: A review of South African studies
Background: Ototoxicity is damage to cells in the inner ear after administering a toxic drug, with a resultant hearing loss. Drugs used to treat illnesses such as cancer, tuberculosis, human immuno-deficiency virus (HIV) and infections are potentially ototoxic. South Africa has one of the highest ra...
Main Authors: | Selvarani Moodley, Claudine Storbeck, Nomthandazo Gama |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2021-03-01
|
Series: | South African Family Practice |
Subjects: | |
Online Access: | https://safpj.co.za/index.php/safpj/article/view/5187 |
Similar Items
-
Insight into the current practice of ototoxicity monitoring during cisplatin therapy
by: N. M. Santucci, et al.
Published: (2021-03-01) -
High incidence of cisplatin-induced ototoxicity in paediatric patients in the Western Cape, South Africa
by: Mukovhe Phanguphangu, et al.
Published: (2018-07-01) -
Parents are aware of the ototoxic effects of chemotherapy in paediatrics undergoing cancer treatment – Professional versus parental views: A pilot study
by: Nomfundo F. Moroe, et al.
Published: (2017-02-01) -
Ototoxicity in patients receiving concurrent cisplatin and cranial irradiation therapy for the treatment of head and neck cancers: an audiometric follow-up
by: Alchin, Katrine Felice
Published: (2010) -
Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program
by: J. Paken, et al.
Published: (2017-12-01)